Despite being in common usage, antidepressants may not treat all aspects of the condition, such as insomnia and reduced concentration, according to results from the largest study on treating depression, now published in April’s edition of the Journal of Clinical Psychopharmacology.
Researchers from University of Texas Southwestern Medical Center looked at how well the most commonly prescribed antidepressants, called selective serotonin reuptake inhibitors (SSRIs), affect symptoms such as concentration, energy levels, appetite and weight, sleep patterns, sadness, and suicidal thoughts.
“Widely used antidepressant medications, while working overall, missed these symptoms. If patients have persistent residual symptoms, these individuals have a high probability of incomplete recovery,” said lead author Dr. Shawn McClintock, assistant professor of psychiatry, in a press release.
Using the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial, the team looked at data from almost 3,000 participants, who completed the first phase on a SSRI for 12 weeks.
They found that around 15 percent of the patients did not experience an alleviation of symptoms, while 33 percent entered remission within the first 12 weeks of treatment, but continued to have some symptoms or new symptoms, in particular insomnia.
“Our findings do suggest that the use of measurement-based care techniques to identify and target residual depressive symptoms is essential to help patients return to normal function and recover from depression in the long term,” said co-author Dr. Madhukar Trivedi.
Interestingly, suicidal thoughts were the least common symptom to arise or recur during treatment.
“Some people fear that antidepressant medication increases thoughts of suicide,” Dr. McClintock said. “This provided counterevidence of that.”
The study findings suggest that even though patients may have a treatment response to SSRI medications, they still suffer from a broad range of residual symptoms, and health professionals should consider treatments based on each individual’s particular symptoms.
The public content above was dynamically discovered – by graded relevancy to this site’s keyword domain name. Such discovery was by systematic attempts to filter for “Creative Commons“ re-use licensing and/or by Press Release distributions. “Source URL” states the content’s owner and/or publisher. When possible, this site references the content above to generate its value-add, the dynamic sentimental analysis below, which allows us to research global sentiments across a multitude of topics related to this site’s specific keyword domain name. Additionally, when possible, this site references the content above to provide on-demand (multilingual) translations and/or to power its “Read Article to Me” feature, which reads the content aloud to visitors. Where applicable, this site also auto-generates a “References” section, which appends the content above by listing all mentioned links. Views expressed in the content above are solely those of the author(s). We do not endorse, offer to sell, promote, recommend, or, otherwise, make any statement about the content above. We reference the content above for your “reading” entertainment purposes only. Review “DMCA & Terms”, at the bottom of this site, for terms of your access and use as well as for applicable DMCA take-down request.
Acquire this Domain
You can acquire this site’s domain name! We have nurtured its online marketing value by systematically curating this site by the domain’s relevant keywords. Explore our content network – you can advertise on each or rent vs. buy the domain. Buy@TLDtraders.com | Skype: TLDtraders | +1 (475) BUY-NAME (289 – 6263). Thousands search by this site’s exact keyword domain name! Most are sent here because search engines often love the keyword. This domain can be your 24/7 lead generator! If you own it, you could capture a large amount of online traffic for your niche. Stop wasting money on ads. Instead, buy this domain to gain a long-term marketing asset. If you can’t afford to buy then you can rent the domain.
About Us
We are Internet Investors, Developers, and Incubators- operating a content network of several thousand sites while federating 20+ eCommerce and SaaS startups. With our proprietary “inverted incubation” model, we leverage a portfolio of $15M+ in valued domains to impact online trends, traffic, and transactions. We use robotic process automation, machine learning, and other proprietary approaches to power our content network. Discover our work!
Monitoring tools, like cookies, are in use. Continued access to this site indicates your acceptance of Cookie settingsAcceptNo
GDPR & CCPA Notices
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
